Disulfide-containing IgG-, Fc-, or albumin-based prodrugs that rely on FcRn-trafficking by endothelial cells for prolonged circulation in the body might be hampered by premature bio-reduction processes during FcRn-mediated recycling events. A detailed bio-reduction analysis of redox-sensitive albumin conjugates in two FcRn-expressing cell lines has been performed. The obtained results indicate that the FcRn-mediated recycling pathway is not (or is only poorly) bio-reducing.

Disulfide‐containing IgG‐, Fc‐, or albumin‐based prodrugs that rely on FcRn‐trafficking by endothelial cells for prolonged circulation in the body might be hampered by premature bio‐reduction processes during FcRn‐mediated recycling events. A detailed bio‐reduction analysis of redox‐sensitive albumin conjugates in two FcRn‐expressing cell lines has been performed. The obtained results indicate that the FcRn‐mediated recycling pathway is not (or is only poorly) bio‐reducing.